Alphabet was among the investors in the latest round for life sciences spinoff Verily, which has now disclosed $2.5bn in funding across three rounds.
Verily, a US-headquartered developer of data-focused life sciences technology, received $700m in funding yesterday from investors including its parent company, internet and technology conglomerate Alphabet. The company said the funding was provided by its current investors and named private equity firm Silver Lake, Singaporean state-owned investment firm Temasek and pension fund manager Ontario Teachers’ Pension…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.